Windlas Biotech Limited — Important, 21-05-2026: Updates

Windlas Biotech's committee approved granting 37,000 employee stock options/units under ESOS 2023 and Windlas Plan 2025. Each unit converts to one Rs 5 face value equity share. This move aims to align employee interests, with vesting periods ranging 1-4 years. Potential for future equity dilution.